ORTHOPOXVIRUS GENOMICS AND BIOINFORMATICS RESOURCE CENTE
正痘病毒基因组学和生物信息学资源中心
基本信息
- 批准号:6534309
- 负责人:
- 金额:$ 49.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-27 至 2004-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Of the potential organisms that might be used in bioterrorism, smallpox would likely have the most horrific impact on the health of the U.S. Small pox is highly Contagious and mortality is in the range of 30%. There is no available antiviral therapy. Furthermore, the U.S. population is essentially entirely susceptible because routine immunization was terminated in the early 1960's. Even older vaccines are vulnerable as vaccine protection wanes significantly after ten years. As a result of the eradication of the disease, and with the exception of the development of fowlpox vaccine vectors, the amount of research on smallpox and related poxviruses has decreased significantly. This proposal will support the acquisition and analysis of orthopoxvirus genomic information to facilitate its application to the development of therapies and improved vaccines for smallpox and related viruses. The goals of the project are: 1) Collect and/or determine the genomic sequences of variola virus isolates and orthopoxviruses that might serve as surrogates for variola virus in animal models; 2) Design and maintain a relational database to store, display, annotate and query genome sequence, structural information, phenotypic data (e.g. drug susceptibility, virulence, host specificity) and bibliographic information; 3) Apply innovative methods for global functional analysis of the viral genomes; 4) Serve as a repository of well-documented viral strains (including clinical isolates and mutants, if relevant) and genomic clones that are used in the genomic sequence analysis; and 5) Develop and maintain a website.
在可能用于生物恐怖主义的潜在生物中,天花可能对美国的健康造成最可怕的影响。天花具有高度传染性,死亡率在30%左右。目前还没有可用的抗病毒疗法。此外,美国人口基本上完全易受影响,因为常规免疫在20世纪60年代初被终止,S。即使是较旧的疫苗也很脆弱,因为疫苗保护力在10年后显著减弱。随着这种疾病的根除,除了开发鸡痘疫苗载体外,关于天花和相关天花病毒的研究数量大幅减少。这项提议将支持获取和分析正痘病毒基因组信息,以促进将其应用于天花和相关病毒的治疗方法和改进疫苗的开发。该项目的目标是:1)收集和/或确定可用作动物模型中天花病毒替代品的天花病毒分离株和正痘病毒的基因组序列;2)设计和维护一个关系数据库,以存储、显示、注释和查询基因组序列、结构信息、表型数据(例如药物敏感性、毒力、宿主特异性)和书目信息;3)应用创新的方法对病毒基因组进行全球功能分析;4)作为基因组序列分析中使用的有良好记录的病毒株(包括临床分离株和突变株)和基因组克隆的储存库;5)开发和维护网站。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert MARK Buller其他文献
Robert MARK Buller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert MARK Buller', 18)}}的其他基金
Immunodominant epitopes of a smallpox vaccine in humans
人类天花疫苗的免疫显性表位
- 批准号:
6562346 - 财政年份:2002
- 资助金额:
$ 49.96万 - 项目类别:
Immunodominant epitopes of a smallpox vaccine in humans
人类天花疫苗的免疫显性表位
- 批准号:
6653210 - 财政年份:2002
- 资助金额:
$ 49.96万 - 项目类别:
ORTHOPOXVIRUS GENOMICS % BIOINFORMATICS RESOURCE CENTER
正痘病毒%20基因组学%20%%20生物信息学%20资源%20中心
- 批准号:
6229304 - 财政年份:2000
- 资助金额:
$ 49.96万 - 项目类别:
ORTHOPOXVIRUS GENOMICS AND BIOINFORMATICS RESOURCE CENTE
正痘病毒基因组学和生物信息学资源中心
- 批准号:
6663132 - 财政年份:2000
- 资助金额:
$ 49.96万 - 项目类别: